| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.5 | 0.1 |
| Profit before tax | -0.4 | -1.0 |
| Net income | -0.4 | -1.0 |
| EPS (diluted, $ a share) | $-0.07 | $-1.31 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +400.0% |
|---|---|
| Operating margin | -104.0% |
10-Q filed with the SEC, NASDAQ: BGMS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Bio Green Med Solution, Inc.: key numbers
- Share price
- $0.6502Close, Nov 16
- Market cap
- $4.31M
- Shares outstanding
- 6.62MLatest SEC cover page
- Sector
- Trade & Services
- Industry
- Wholesale-Durable Goods, NECSIC 5099
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Bio Green Med Solution, Inc.
All →Bio Green Med Solution Financial Results
Bio Green Med Solution reported Q3 2026 financial results, highlighting a significant increase in fire safety product revenue to $454,000 and a narrowed net loss of $0.4 million. The company also announced that its Form S-4 for the proposed business combination with Future NRG Sdn. Bhd. has been declared effective, with a shareholder vote planned for November 2026.
- Term
- Q3 2026
“During the third quarter, our fire safety business generated $454,000 in product revenue, compared to $81,000 in the prior-year period, and yielded a gross margin of approximately 25%, while our net loss narrowed to $0.4 million from $1.0 million in the prior-year period.”
Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director
“We also reduced general and administrative expenses by 37% year over year and ended the quarter with $3.5 million in cash and cash equivalents.”
Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director
Bio Green Med Solution Nasdaq/NYSE Compliance Notice
Bio Green Med Solution received a deficiency notice from Nasdaq on October 29, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 27, 2027, to regain compliance and is considering a reverse stock split as a potential remedy in connection with its pending business combination with Future NRG Sdn. Bhd.
- Counterparty
- Nasdaq Stock Market LLC
- Term
- 180 days
Bio Green Med Solution Dividend
Bio Green Med Solution, Inc. declared a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock. The dividend is payable on November 1, 2026, to stockholders of record as of October 26, 2026.